Profiling Response to Tumor Necrosis Factor Inhibitor Treatment in Axial Spondyloarthritis

Alazmi M., SARI İ., Krishnan B., Inman R. D., Haroon N.

ARTHRITIS CARE & RESEARCH, cilt.70, sa.9, ss.1393-1399, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 70 Sayı: 9
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1002/acr.23465
  • Dergi Adı: ARTHRITIS CARE & RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1393-1399
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. Lack of response to tumor necrosis factor inhibitor (TNFi) agents is not uncommon, encountered during the treatment of axial spondyloarthritis (SpA) patients, and it can be classified as primary lack of response (PLR) or secondary lack of response (SLR). The primary aim of this study was to evaluate factors associated with TNFi failure types and their characteristics in axial SpA.